scholarly journals Cell Metabolism Control Through O-GlcNAcylation of STAT5: A Full or Empty Fuel Tank Makes a Big Difference for Cancer Cell Growth and Survival

2019 ◽  
Vol 20 (5) ◽  
pp. 1028 ◽  
Author(s):  
Manuel Rauth ◽  
Patricia Freund ◽  
Anna Orlova ◽  
Stefan Grünert ◽  
Nikola Tasic ◽  
...  

O-GlcNAcylation is a post-translational modification that influences tyrosine phosphorylation in healthy and malignant cells. O-GlcNAc is a product of the hexosamine biosynthetic pathway, a side pathway of glucose metabolism. It is essential for cell survival and proper gene regulation, mirroring the metabolic status of a cell. STAT3 and STAT5 proteins are essential transcription factors that can act in a mutational context-dependent manner as oncogenes or tumor suppressors. They regulate gene expression for vital processes such as cell differentiation, survival, or growth, and are also critically involved in metabolic control. The role of STAT3/5 proteins in metabolic processes is partly independent of their transcriptional regulatory role, but is still poorly understood. Interestingly, STAT3 and STAT5 are modified by O-GlcNAc in response to the metabolic status of the cell. Here, we discuss and summarize evidence of O-GlcNAcylation-regulating STAT function, focusing in particular on hyperactive STAT5A transplant studies in the hematopoietic system. We emphasize that a single O-GlcNAc modification is essential to promote development of neoplastic cell growth through enhancing STAT5A tyrosine phosphorylation. Inhibition of O-GlcNAcylation of STAT5A on threonine 92 lowers tyrosine phosphorylation of oncogenic STAT5A and ablates malignant transformation. We conclude on strategies for new therapeutic options to block O-GlcNAcylation in combination with tyrosine kinase inhibitors to target neoplastic cancer cell growth and survival.

Epigenetics ◽  
2020 ◽  
Vol 15 (12) ◽  
pp. 1302-1318
Author(s):  
Jibran Sualeh Muhammad ◽  
Khuloud Bajbouj ◽  
Jasmin Shafarin ◽  
Mawieh Hamad

2012 ◽  
Vol 31 (5) ◽  
pp. 299-307 ◽  
Author(s):  
Kristina Kapinas ◽  
Katie M. Lowther ◽  
Catherine B. Kessler ◽  
Karissa Tilbury ◽  
Jay R. Lieberman ◽  
...  

Oncotarget ◽  
2018 ◽  
Vol 9 (58) ◽  
pp. 31278-31290 ◽  
Author(s):  
Gerolamo Bevivino ◽  
Silvia Sedda ◽  
Eleonora Franzè ◽  
Carmine Stolfi ◽  
Antonio Di Grazia ◽  
...  

Neoplasia ◽  
2021 ◽  
Vol 23 (1) ◽  
pp. 68-79
Author(s):  
Jibran Sualeh Muhammad ◽  
Maha Guimei ◽  
Manju Nidagodu Jayakumar ◽  
Jasmin Shafarin ◽  
Aisha Saleh Janeeh ◽  
...  

PLoS ONE ◽  
2018 ◽  
Vol 13 (5) ◽  
pp. e0197422 ◽  
Author(s):  
Colin H. Beckwitt ◽  
Keisuke Shiraha ◽  
Alan Wells

2012 ◽  
Vol 19 (3) ◽  
pp. 560-570 ◽  
Author(s):  
Mohamed Hassanein ◽  
Megan D. Hoeksema ◽  
Masakazu Shiota ◽  
Jun Qian ◽  
Bradford K. Harris ◽  
...  

Cancers ◽  
2019 ◽  
Vol 11 (6) ◽  
pp. 804 ◽  
Author(s):  
Jie Jiang ◽  
Sankalp Srivastava ◽  
Ji Zhang

Distinct from normal differentiated tissues, cancer cells reprogram nutrient uptake and utilization to accommodate their elevated demands for biosynthesis and energy production. A hallmark of these types of reprogramming is the increased utilization of, and dependency on glutamine, a nonessential amino acid, for cancer cell growth and survival. It is well-accepted that glutamine is a versatile biosynthetic substrate in cancer cells beyond its role as a proteinogenic amino acid. In addition, accumulating evidence suggests that glutamine metabolism is regulated by many factors, including tumor origin, oncogene/tumor suppressor status, epigenetic alternations and tumor microenvironment. However, despite the emerging understanding of why cancer cells depend on glutamine for growth and survival, the contribution of glutamine metabolism to tumor progression under physiological conditions is still under investigation, partially because the level of glutamine in the tumor environment is often found low. Since targeting glutamine acquisition and utilization has been proposed to be a new therapeutic strategy in cancer, it is central to understand how tumor cells respond and adapt to glutamine starvation for optimized therapeutic intervention. In this review, we first summarize the diverse usage of glutamine to support cancer cell growth and survival, and then focus our discussion on the influence of other nutrients on cancer cell adaptation to glutamine starvation as well as its implication in cancer therapy.


Sign in / Sign up

Export Citation Format

Share Document